Find investors who align with your industry, stage, and vision. Unlock Laia Crespo’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors todayLaia Crespo is a Venture Capital, Corporate Venture Capital, Investor based in Paris, Île-de-France, France with a diverse investment portfolio that includes companies such as Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion, NeuroVia, Medisafe, Lysosomal Therapeutics, Sirtris Pharmaceuticals, UNUM Therapeutics, Immune Design, Common Sensing, GlycoMimetics, NGI, Yumanity Therapeutics, KAHR medical, Kymera Therapeutics, Ovid Therapeutics, Expansion Therapeutics, Imbria Pharmaceuticals, Cogent Biosciences, Bluebird Bio, Abcuro, NodThera, Fate Therapeutics, MinervaxOmada Health, Selecta Biosciences, Edimer Pharmaceuticals, Icosavax, Navitor Pharmaceuticals, DiCE Molecules, Ysios Capital, Escient Pharmaceuticals, Evidation Health, Curisium, Click Therapeutics, Q32 Bio, Veralox Therapeutics, Lumena Pharmaceuticals, Lava Therapeutics, Inozyme, i2o Therapeutics, . Over time, Laia Crespo has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Laia Crespo is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Research and Development, Drug Discovery, Wellness, Women Founded, Rare Diseases, Healthcare Innovation, Life Science, Emerging Markets, Health Technology, Diabetes, Business Development, Mobile, Manufacturing, Biotechnology, Drug Development, Innovation, Neuroscience, Clinical Trials, Digital Transformation, Research, Vaccines, Personalized Medicine, Mergers and Acquisitions, Social Impact, Digital Health, Renewable Energy, Medical, Information Technology, B2B, Therapeutics, Molecular Diagnostics, Personal Health, Pharmaceuticals, Healthcare Technology, Acquisitions, Oncology may find it worthwhile to explore potential connections with Laia Crespo, as their portfolio suggests a familiarity and interest in this area.
Understanding Laia Crespo’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today